Evidence map›Paper›PMID 31632549›Full record

ArticleAmerican journal of translational research2019

Lymphoma of the female genital tract: a clinicopatholngical analysis of 25 cases.

Jingping Wang, Linggong Zeng, Shoukang Chen, Qiong Wu, Li Ma, Shiwu Wu, Z Peter Wang, Yisheng Tao, Damin Chai

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jingping WangDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Linggong ZengDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Shoukang ChenDepartment of Radiology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Qiong WuDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Li MaDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Shiwu WuDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Z Peter WangDepartment of Biochemistry and Molecular Biology, School of Laboratory Medicine, Bengbu Medical College Bengbu 233030, Anhui, China.
Yisheng TaoDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Damin ChaiDepartment of Pathology, The First Affiliated Hospital of Bengbu Medical University, Bengbu Medical University Bengbu, Anhui, China.
Harvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Occurrence of lymphoma of the female genital tract (FGT) is extremely rare, and cohort studies on survival rates of affected patients are sparse. The aim of this study was to retrospectively evaluate the clinicopathological characteristics of patients diagnosed with non-Hodgkin lymphoma of the FGT. This study included 25 women diagnosed with lymphoma of the FGT. Their data on presenting pathological subtype, International Federation of Gynecology and Obstetrics (FIGO) and Ann Arbor staging, International Prognostic Index (IPI) score, treatment, and survival time were collected. Among the 25 patients, the most prevalent histological subtype was diffuse large B-cell lymphoma (23/25). Tumors were most commonly located in the ovary (15/25), with the remainder located in the cervix (7/25) and uterine corpus (3/25). 76% of cases by Ann Arbor were stage III or IV, and 70% of cases by FIGO were stage III or IV. The overall median survival from diagnosis of lymphoma was estimated to be 71 months, with 3-year and 5-year survival rates of 92% and 80%, respectively. The FIGO and Ann Arbor staging and IPI score were significantly correlated with overall survival time.

Indexed as

ann arbor stageFGTFIGOLymphomasurvival time

Identifiers

PMID31632549
PMCPMC6789275
OpenAlexW2989568582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.